fbpx

Tag: psa

Contact Us

Contact us on 1300 369 772 Monday to Friday, business hours

Share this page

PSA set to negotiate and sign new pharmacy programs agreement

31 January 2025

 

The Pharmaceutical Society of Australia (PSA) are set to negotiate the first dedicated agreement on pharmacy programs with the Australian Government. PSA will be signatory to this agreement.

 

The agreement will cover a range of pharmacy programs that no longer sit within the 8th Community Pharmacy Agreement, including but not limited to medication management programs (including Home Medicines Reviews and Residential Medication Management Reviews), Aboriginal and Torres Strait Islander specific programs, and rural support programs that encompass pharmacists in a range of practice areas.

 

The new agreement will see PSA and the Commonwealth work together, alongside other pharmacy stakeholders, to strengthen programs that pharmacists deliver across the health system.

 

PSA National President Associate Professor Fei Sim FPS said the agreement was an opportunity to reform programs to ensure they are fit-for-purpose, now and into the future.

 

“PSA is the recognised peak body for all pharmacists, in all areas of practice across our health system. This agreement is an opportunity to reform program rules and funding arrangements to maximise the impact of pharmacists across the health sector,” Associate Professor Sim said.

 

“In negotiating a standalone agreement with the Australian Government, we are advocating for the changes we have long known need to happen, allowing pharmacists to best serve our communities.

 

“Members will be aware that following PSA’s advocacy, the government confirmed in late 2024 that these programs would have ongoing funding beyond the current financial year. Now that there is security of funding for these programs, our focus turns to removing the barriers that have prevented pharmacists from playing a greater role in patient care.”

 

As signatory to the new agreement, PSA will be seeking feedback from pharmacists and stakeholders on program arrangements and barriers.

 

“I encourage every pharmacist involved in these programs to have their say so that we can provide a full picture of the barriers, challenges and opportunities for pharmacists to provide better care for patients.

 

“PSA looks forward to continuing our work with the federal government to secure a stronger pharmacy profession now and into the future,” Associate Professor Sim concluded.

 

PSA consultant pharmacist adviser Debbie Rigby FPS also welcomed the announcement.

 

“As the home for credentialed pharmacists, it’s important that PSA is the organisation leading these discussions,” Ms Rigby said.

 

“I’m excited to be part of PSA’s team, advocating for improvements to these programs. As someone with a deep understanding of the current programs, I am committed to raising awareness of the benefits of these programs and further enhancing outcomes for patients.”

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

PSA announce intent to acquire Australasian College of Pharmacy

28 January 2025

 

The Pharmaceutical Society of Australia (PSA) Board has today announced plans to acquire the Australasian College of Pharmacy, further growing PSA’s leadership in education and training for pharmacists, pharmacy assistants, and technicians.

 

The Australasian College of Pharmacy (the College) is a member-based organisation developing and delivering education, training, and research programs to pharmacists and pharmacy assistants since 1976.

 

The decision to acquire the College is part of the PSA Board’s broader plan to maximise member value through growth, expanding education opportunities for the profession, and securing a long-term, sustainable future for PSA as the premier training and education provider for pharmacists, pharmacy assistants and technicians.

 

PSA’s acquisition of the College builds on its long history of high-quality, nation-leading education and training for pharmacists, allowing further investment in professional and practice support for members.

 

The PSA Board has carefully considered the impact of acquiring the College, and alongside independent advice from third-party experts the Board is confident this is the right path forward for PSA, its members, and the broader profession.

 

National President and Chair of the PSA Board Associate Professor Fei Sim FPS said the acquisition will be a transformational opportunity to grow PSA’s industry-leading education and workforce development offer.

 

“The PSA Board’s strategic decision to acquire the Australasian College of Pharmacy secures a long-term future for pharmacy workforce education. It puts PSA in a stronger representative and financial position to support and advocate for our members during this pivotal time of practice change in pharmacy,” Associate Professor Sim said.

 

“Along with the PSA Board, I fully understand the challenges pharmacists are facing, as we transition to full scope of practice and our roles become increasingly demanding.

Growing our footprint within pharmacy education means we can further invest in not only education, but also the professional and practice support PSA provides. As our profession continues to mature, this unity will provide the necessary strength our profession needs at this critical time of change to fully utilise our skills and expertise.

 

“We are ambitious about our future growth as an organisation, as the peak education and representative body for all pharmacists across all areas of practice.

 

“We look forward to being able to provide even more education opportunities and support to pharmacists, pharmacy assistants and technicians, strengthening our pharmacy profession and ultimately improving care for our patients,” Associate Professor Sim concluded.

 

ACP Chief Executive Officer Amanda Seeto said the College and the PSA had always shared a commitment to providing contemporary education and training in a format that is accessible, efficient, and most importantly – highly relevant to Australian pharmacists.

 

“This exciting and pragmatic change maximises the focus on world-leading professional development for Australian pharmacists, no matter their practice setting or career stage.

 

“The move will set our sector up for success, at a time when pharmacy is becoming an increasingly valued frontline health service.”

 

PSA members are set to vote on matters relating to the acquisition at an upcoming meeting.

 

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

PSA and Audirie mark first year of partnership, announcing expansion of AI-powered education simulations in 2025

5 December 2024

The Pharmaceutical Society of Australia (PSA) and Audirie are celebrating the first anniversary of partnership, empowering thousands of learners through immersive AI-powered simulations and enhancing their patient counselling and clinical communication skills.

 

In the first year of partnership, PSA and Audirie have:

  • Empowered thousands of pharmacists, interns, and pharmacy assistants through immersive AI-powered simulations.
  • Enhanced patient counselling and clinical communication skills with cutting-edge technology tailored to the unique needs of pharmacy professionals.
  • Strengthened our shared commitment to excellence in education and improved health outcomes for communities across Australia.

 

PSA is expanding use of AI-powered pharmacist prescriber simulations in 2025, giving more learners access to nation-leading technology.

 

PSA National President Associate Professor Fei Sim FPS expressed her enthusiasm for the ongoing partnership and the upcoming launch of the AI-powered simulations.

 

“Our collaboration with Audirie is boosting the capacity of our education programs to deliver real-world experience for pharmacists, interns and assistants, setting them up to succeed in new roles,” Associate Professor Sim said.

 

“Integrating pharmacist prescriber simulations means learners will be able to practically apply knowledge, counselling and prescribing for an AI-driven patient in real-life clinical scenarios.

 

“PSA is proud to be leading the integration of artificial intelligence in pharmacist education, giving our learners the best and most comprehensive education experience in the Australian market.”

 

Audirie Co-founder and CEO Michael Alexander also highlighted the utilisation of AI as a powerful tool in improving learning outcomes.

 

“Our partnership with PSA has been a transformative journey. Over the past year, we’ve empowered pharmacists, pharmacy assistants and pharmacy interns with cutting-edge AI simulations that enhance their skills and confidence. Together, we are shaping the future of pharmacy education and professional development in Australia.”

 

“The integration of AI into the upcoming PSA Pharmacist Prescriber modules represents the next step in our shared vision to elevate the profession. By combining innovative technology with PSA’s expertise, we are equipping pharmacists with tools to excel in their evolving roles and deliver better patient outcomes.”

 

About Audirie

Audirie is a leading provider of AI-driven communication solutions, committed to transforming the way individuals learn and grow. With a focus on immersive learning experiences, Audirie harnesses the power of artificial intelligence to deliver innovative and effective training programs across various industries.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

​

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

Share this page
Share this page

PSA introduces community of practice for consultant pharmacists

24 October 2024

 

 

The Pharmaceutical Society of Australia (PSA) has established the Consultant Pharmacist Community of Specialty Interest (CSI), taking the reins from the Interdisciplinary team-based care CSI established in 2021.

 

The Consultant Pharmacist CSI will work with PSA to:

  • Encourage engagement and professional growth among consultant pharmacists through collaborative learning and foster discussions and idea-sharing to enrich the community’s collective knowledge and expertise.
  • Deliver Practical Workshops on essential topics for consultant pharmacists.
  • Gather insights from members to shape the Consultant Pharmacist Conference, emphasising themes like patient-centred care and lived experiences.
  • Strengthen professional recognition and visibility within the field for consultant pharmacists.

 

PSA National President Associate Professor Fei Sim FPS said the time was right to establish a dedicated community for consultant pharmacists and thanked the outgoing members of the CSI for their leadership.

 

“The outgoing leadership team have advised PSA on issues relating to consultant pharmacists and interdisciplinary team-based care during a period of significant change and uncertainty for this portion of our profession,” Associate Professor Sim said.

 

“On behalf of PSA I sincerely thank this experienced group of leaders for providing insights into the consultant pharmacist space and informing our work in this area over the last three years. Of course, we are proud to harness the experience and knowledge of outgoing CSI Chair Debbie Rigby, who continues to work with PSA in an advisory role helping lead, shape and further scale up our support for credentialed pharmacists.

 

“Now is the right time for PSA to refresh the CSI to reflect our growing community of consultant pharmacists specialising in general practice, aged care and medication management.

 

“Our CSIs are a forum for PSA members to connect with colleagues, share ideas, opportunities and resources, and grow their practice in a safe, professional environment. I encourage members to join our CSIs and take advantage of the professional communities they offer.”

 

Incoming CSI Chair Deborah Hawthorne FPS also extended a special thanks to outgoing chair Debbie Rigby FPS.

 

“Under Debbie’s leadership this CSI has established itself as an important advisory group for PSA and we thank her for her input and guidance. We’re also very excited that she is staying on as a member of the CSI Leadership group to mentor us and continuing providing valuable input.

 

“The consultant pharmacist community in Australia is going through a time of great change, but also a time where new opportunities are presenting themselves. I’m excited to be leading this CSI and hope to be able to use this role to guide PSA in providing tailored support and resources to consultant pharmacist members.

 

“This is a really exciting time to be a consultant pharmacist and I’m looking forward to using the Consultant Pharmacist CSI platform to help pharmacists get the most out of every opportunity that presents itself.”

 

The Consultant Pharmacist Community of Specialty Interest is led by:

  • Deborah Hawthorne FPS (chair)
  • Kelly Abbott MPS
  • Manya Angley FPS
  • Lily Chong MPS
  • Erin Colreavy MPS
  • Sharon Doolan MPS
  • Joanne Gross MPS
  • Bente Hart MPS
  • Nick Mamas MPS
  • Lucy Parker MPS
  • Debbie Rigby FPS
  • Rania Saad MPS
  • Brooke Shelly FPS
  • Brooke Snow MPS
  • Raymond Truong MPS
  • Kristin Turner MPS

 

The Consultant Pharmacist – Community of Specialty Interest is an exclusive forum for PSA members. Join PSA today by visiting www.psa.org.au/membership​​

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

Celebrating Australia’s pharmacy technicians and assistants

15 October 2024

 

Today, the Pharmaceutical Society of Australia (PSA) proudly celebrates Pharmacy Technicians and Assistants Day, recognising Australia’s dedicated pharmacy support staff who work tirelessly to ensure smooth operations and enhance the quality of care we deliver to patients every day – particularly in rural and regional areas.

 

PSA National President Associate Professor Fei Sim FPS emphasised the critical role that pharmacy technicians and assistants play in supporting clinical services.

 

“As the scope of practice for many pharmacists continues to expand, the role of pharmacy assistants and technicians is becoming even more integral to everything we do. From administrative or backend support to direct patient interactions, their contribution to the overall team capacity and efficiency is invaluable,” she said.

 

Pharmacy technicians and assistants are not only involved in the operational aspects of pharmacy practice; they are increasingly taking direct responsibilities to support the role of pharmacists in clinical settings.

 

“The clinical support that technicians and assistants provide allows pharmacists to extend their focus to undertaking clinical roles and practising to their full and top of scope, including in the long term management of diseases, preventive health services, and complex medication therapy,” Associate Professor Sim added. “Their contributions are vital to the seamless integration of clinical services in our pharmacies, ultimately improving health outcomes for our communities.”

 

Associate Professor Sim encouraged all pharmacists to take a moment today to acknowledge the dedication and hard work of their technicians and assistants. “Whether through a formal recognition event or simply a kind word of appreciation, today is a day to show our gratitude for their vital role in the pharmacy profession,” she said.

 

On this Pharmacy Technicians and Assistants Day, the PSA extends its heartfelt thanks to all pharmacy support staff for their tireless efforts and commitment to improving the health and well-being of Australians.

​

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

PSA welcomes 8th Community Pharmacy Agreement, and enters into Strategic Agreement on Pharmacist Professional Practice

3 June 2024

 

 

The Pharmaceutical Society of Australia (PSA) welcomes the announcement today that the Australian Government and Pharmacy Guild of Australia has finalised the 8th Community Pharmacy Agreement. PSA welcomes the certainty the 8CPA brings to the community pharmacy sector, and confidence it brings to the viability of Australia’s community pharmacies.

 

For the last 12 months, the community pharmacy sector has had uncertainty. The 8CPA delivers funding boost of $3billion for community pharmacy activities, certainty of funding for dose administration aids, staged supply, MedsChecks and the Regional Pharmacy Maintenance Allowance.

 

PSA has also announced the signing of the Strategic Agreement on Pharmacist Professional Practice was signed in Canberra today by National President A/Prof Fei Sim and the Minister for Health and Aged Care the Hon. Mark Butler.

 

The key Strategic Agreement with the Australian Government contains a program of work to deliver contemporary fundamental standards and guidelines that define pharmacy practice across all areas of practice.

 

Together, both agreements secure the most significant federal government commitment to supporting professional pharmacy practice in history, lifting the bar in quality of care and breadth of services delivered by pharmacists across the health system.

 

Discussions will continue for programs not contained in the 8CPA, including those delivered by pharmacists in all other areas of practice. PSA looks forward to leading further engagement with government in relation to these programs during the remainder of 2024.

 

Quotes attributable to PSA National President Associate Professor Fei Sim:

 

“On behalf of our members, PSA welcomes the signing of the 8th Community Pharmacy Agreement for the certainty it provides the sector. The funding committed by the Albanese government in the 8CPA is positive for community pharmacies and will result in more accessible care for patients through a strong, thriving and viable community pharmacy network.

 

“In particular, I thank Minister for Health and Aged Care Mark Butler for his commitment, alongside PSA, to continue advancing the profession through a key Strategic Agreement on pharmacy practice.

 

“PSA’s intent through its negotiations with government is to ensure pharmacists are supported to do what they do best – support the health and wellbeing of Australians through providing access to health care and making the use of medicines safer.

 

“PSA’s Strategic Agreement on Pharmacist Professional Practice acknowledges that the role of pharmacists is changing and evolving, and with that comes the need to further develop the fundamental guidelines that underpin all elements and areas of pharmacy practice. This will ensure pharmacists can continue to deliver high standards and quality services which Australians rely on in a sustainable manner.

​

“While today is a milestone in negotiations regarding community pharmacy-delivered programs and services with government, there is more to be done.

​

“We are focused in continuing our work with Minister Butler and the Department of Health and Aged Care which will define the design, implementation and evaluation of pharmacist-led programs which are not in the 8CPA.

​

“We continue our commitment on supporting the pharmacy workforce through practice support and education which has always been one of the core responsibilities of the PSA.”

​

Quotes attributable to PSA Lead Negotiator Dr Shane Jackson:

 

“The 8PCA is a positive outcome for the profession and the Australian community. It will help improve access to care in a sustainable manner.

​

“PSA’s strategic agreement focuses on supporting pharmacists, and helping pharmacists demonstrate the value of what we do. It provides a pathway to create data and evidence to demonstrate the need for long-term, continued funding for programs we know are critical to the Quality Use of Medicines.

​

“Now that the 8CPA and Strategic Agreement on Pharmacist Professional Practice have been announced, we turn our focus to providing a structure for optimisation of programs no longer contained in the 8CPA, as well as new programs that may be delivered by pharmacists.”

 

 

A copy of the PSA Strategic Agreement on Pharmacist Professional Practice is available on the Department of Health website.

​

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

Federal Budget makes medicines more accessible

15 May 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes the Albanese Government’s 2024-25 federal budget, making healthcare more accessible to Australians through cost-of-living relief and expanded pharmacy programs.

 

Australians will have access to cheaper medicines under the Pharmaceutical Benefits Scheme, with a freeze on indexation for at least one year ensuring that the cost of medicines does not rise with the cost of living. On top of this, all PBS medicines dispensed by a community pharmacy, hospital, or approved prescriber will now be covered by the Closing the Gap PBS co-payment, making essential medicines free or cheaper for First Nations people.

 

The government are also set to invest $151.1 million to improve access to dose administration aids (DAAs), lifting the service cap from 60 to 90 services per pharmacy per week.

 

The Budget has also reaffirmed Commonwealth support for the Aged Care On-site Pharmacists (ACOP) program, investing $333.7 million to embed credentialed pharmacists in aged care facilities from 1 July 2024. Critically, the Budget also confirmed funding for pharmacists to deliver vaccination services in aged care and disability homes, actioning one of PSA’s key recommendations in its 2024-25 Federal Budget Submission.

 

PSA National President Associate Professor Fei Sim welcomed the Budget, saying that measures to tackle the cost of healthcare are critical to improving accessibility of care.

 

“Slowing down the rising cost of medicines is essential to ensuring that basic healthcare remains accessible despite the rising cost of living,” Associate Professor Sim said.

 

“Measures like lifting the cap on dose administration aids and investing in PBS medicines access for First Nations people are a step in the right direction, ensuring that support is rightly focused on priority populations.

 

“Closing the Gap must continue to be a priority for the entire health sector. PSA continues to promote measures that support greater health outcomes for First Nations people, including improving access to essential medicines.

 

“As negotiations on the 8th Community Pharmacy Agreement and other agreements continue, PSA is highlighting the importance of funding for the delivery and quality improvement of pharmacist programs to further support patient safety.

 

“We continue to highlight that pharmacists are key to improving Australians ’access to care and quality use of medicines and medicine safety.”

 

Associate Professor Sim also acknowledged the $160 million investment in women’s health initiatives included in this year’s budget.
 

“I sincerely thank Assistant Minister for Health and Aged Care Ged Kearney MP for her continued advocacy for women’s health. It is positive to see investment into women’s health in this year’s budget.

 

 

“This is only the start of the journey, and I look forward to working collaboratively with the government, the Department and other stakeholders on this important work. ’

 

“On behalf of PSA and Australia’s 37,000 pharmacists, I commend Minister for Health and Aged Care Mark Butler, Treasurer Jim Chalmers MP on delivering today’s Budget.”

​

 

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

Vaping reforms to protect a new generation from nicotine dependence

8 May 2024

 

The Pharmaceutical Society of Australia (PSA) joins leading health bodies and the Federal Government in calling for reforms to the sale, supply, manufacture and commercial possession of vapes to pass Parliament.

 

PSA National President Associate Professor Fei Sim said Australians do not want to see a new generation of Australians taking up smoking or vaping.

 

“PSA unreservedly supports any measure that reduces the chance of children and young people accessing vapes and support Australia’s world leading approach to tobacco control,” A/Prof Sim said.

 

“Our priority focus in public health messaging and in policy should continue to be on the harms of cigarette smoking and vaping, particularly to young people and children.

 

“Ensuring convenience stores do not sell vapes and removing the colours and flavourings that appeal to young people are the first steps to reducing the harm of nicotine vapes.

 

“There are no nicotine vaping products on the market that have been tested and approved by the Therapeutic Goods Administration as safe therapeutic goods, but there are pathways for vaping products to be used as a genuine smoking cessation tool with the support of healthcare professionals.

 

“We need to be clear that vaping is not a ‘safe’ alternative to smoking – we’re already seeing scary short-term effects, not to mention the long-term effects that may emerge in the coming years.

 

“Accessing vaping products through a health professional gives pharmacists the opportunity to provide broader health and smoking cessation support.”

 

PSA is already assisting government with minimising the impacts of vaping in the community.

 

A/Prof Sim said: “PSA is supporting pharmacists across Australia with education and training about our role in vaping and smoking cessation.

 

“There is more work to be done to limit the harm caused by vaping and inhaled nicotine use in general. PSA continues to work with the Federal Government, the Department of Health, the Pharmacy Guild of Australia and other stakeholders to ensure that pharmacists have all necessary resources and education to support vaping reform,” A/Prof Sim concluded.
​

 

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

Thanking your pharmacist is more important than ever

13 March 2024

 

The Pharmaceutical Society of Australia (PSA) is proud to announce the 2024 theme for Thank Your Pharmacist Day – More than ever.

​

More than ever highlights pharmacists’ growing role in Australia’s health care system, and the enduring commitment of pharmacists in all practice areas and specialisations to quality, accessible care.

​

Thank Your Pharmacist Day is celebrated annually in March, bringing together patients, community leaders and stakeholders from across the health sector to acknowledge the vital work of Australia’s pharmacists.

​

PSA National President Associate Professor Fei Sim FPS said that support for pharmacists, across all practice areas and specialisations, was more important than ever.

​

“Our profession is doing more to support the health and wellbeing of Australia than ever before,” A/Prof Sim said.

​

“We are accessible in communities, offering more services, delivering more vaccinations, and making critical medicines more accessible to all Australians regardless of where they live. In many states and territories, we are strengthening access to oral contraceptives and treatments for uncomplicated UTIs, and in some parts of the country, providing more care for minor skin conditions.

​

“We are providing more medication management reviews, and supporting multidisciplinary care in general practice, Aboriginal Community Controlled Health Organisations, and aged care facilities. We are supporting the quality use of medicines in hospitals, working with doctors, nurses, and allied health professionals in a range of settings—from inpatient bedsides to emergency departments and outpatient clinics.

​

“Each of these roles and the countless other specialist areas of practice are critical to the future of our health care systems.

​

“Thank Your Pharmacist Day is an opportunity for all Australians to consider all the ways in which pharmacists support our health. I strongly encourage all Australians to thank their pharmacist every time you visit a pharmacy, but especially on the 21st of March – national Thank Your Pharmacist Day.”

 

Thank Your Pharmacist Day is celebrated on 21 March 2024.

For more information visit www.psa.org.au/thankyourpharmacist

​

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Share this page
Share this page

More Victorians to access travel health and skin services from community pharmacists

28 February 2024

 

More Victorian pharmacists will soon be delivering expanded vaccination, travel health services and treatment for two common skin conditions as the Pharmaceutical Society of Australia (PSA) launches a series of brand-new training programs.

​

PSA’s Travel Health training program provides pharmacists with an understanding of the key health risks associated with international travel, and outlines preventative strategies including travel vaccinations.

​

PSA’s Herpes Zoster (Shingles) and Mild plaque psoriasis training programs provide pharmacists with a comprehensive clinical understanding the conditions, covering clinical features, treatment approach, management goals, and practical applications for pharmacists participating in prescribing pilots.

​

The successful completion of these programs enable Victorian pharmacists to offer new services under the Victorian Community Pharmacist Statewide Pilot.

​

PSA Victoria President Dr Amy Page FPS says that PSA is proud to build on existing support for Victorian pharmacists to deliver high quality care to patients as pharmacist scope continues to evolve.

​

“We’re excited to offer more support for Victorian pharmacists to grow the scope of their practice under the Victorian Community Pharmacist Statewide Pilot,” Dr Page says.

​

“More pharmacists will soon be providing treatment for common skin conditions herpes zoster and mild plaque psoriasis flare ups, as well as delivering travel health services. These services, embedded in our local communities means more accessible care for Victorians.

​

“Pharmacists can now complete training programs in both travel health and skin conditions and offer additional health services backed by nation-leading education and professional support.

​

“PSA is proudly committed to ensuring that pharmacists are supported with the knowledge and skills required to support Victorians with greater access to health advice in these key clinical areas.”

​

PSA’s Travel Health and Herpes Zoster (Shingles) and Mild plaque psoriasis modules are available now, free for PSA members.

​

​

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

​

Share this page

In the spirit of reconciliation, the Pharmaceutical Society of Australia (PSA) acknowledges the Traditional Custodians of Country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today. We recognise that Aboriginal and Torres Strait Islander peoples were our first pharmacists.

CONTACT US | TERMS OF USE | PRIVACY

© 2025 Pharmaceutical Society of Australia Ltd. All rights reserved.